Chun-Bing Chen Selected Research

Allopurinol (Remid)

1/2023	DNA methylation of ITGB2 contributes to allopurinol hypersensitivity.
1/2020	Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions.
1/2019	Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Bing Chen Research Topics

Disease

14	Stevens-Johnson Syndrome (Lyell's Syndrome) 04/2024 - 01/2017
11	Hypersensitivity (Allergy) 05/2024 - 01/2018
11	Cicatrix (Scar) 04/2024 - 01/2018
7	Drug Hypersensitivity Syndrome 04/2024 - 01/2018
7	Neoplasms (Cancer) 12/2023 - 01/2018
5	Eosinophilia 01/2023 - 01/2018
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2018
4	Inflammation (Inflammations) 04/2024 - 01/2019
4	Blister (Bulla) 10/2023 - 05/2017
4	Infections 02/2021 - 07/2015
4	Drug Hypersensitivity (Drug Allergy) 01/2021 - 01/2018
4	Exanthema (Rash) 01/2019 - 01/2018
3	Atopic Dermatitis (Atopic Eczema) 05/2024 - 10/2022
3	Pruritus (Itching) 10/2023 - 01/2022
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2023 - 01/2022
3	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2019
2	Mycoplasma Infections 12/2023 - 09/2022
2	Alopecia (Baldness) 10/2023 - 01/2019
2	Dermatitis 09/2023 - 02/2023
2	Wounds and Injuries (Trauma) 09/2022 - 01/2019
2	Gastrointestinal Hemorrhage (Hematochezia) 01/2022 - 01/2018
2	Fever (Fevers) 01/2022 - 01/2021
2	Necrosis 01/2018 - 08/2017
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 05/2024
1	Asthma (Bronchial Asthma) 05/2024
1	Vitamin D Deficiency 04/2024
1	Ovarian Neoplasms (Ovarian Cancer) 12/2023
1	Bullous Pemphigoid (Pemphigoid) 10/2023
1	Alopecia Areata 10/2023
1	COVID-19 10/2023
1	Perioral Dermatitis 09/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2023
1	Adenocarcinoma of Lung 02/2023
1	Mucositis 02/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2023
1	Trichiasis 01/2023
1	Keloid 01/2023
1	Keratitis 01/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2023
1	Chronic Urticaria 01/2023
1	Leukopenia 11/2022
1	Exfoliative Dermatitis (Erythroderma) 11/2022
1	Psoriatic Arthritis 11/2022

Drug/Important Bio-Agent (IBA)

8	HLA-B Antigens (HLA-B)IBA 04/2024 - 01/2018
8	HLA Antigens (Human Leukocyte Antigens)IBA 04/2024 - 01/2018
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2021
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 07/2023 - 10/2019
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024 - 01/2018
4	COVID-19 VaccinesIBA 04/2024 - 11/2022
4	Etanercept (Enbrel)FDA Link 03/2024 - 01/2018
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2023 - 01/2018
4	CytokinesIBA 01/2022 - 05/2017
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 02/2021
3	Tyrosine Kinase InhibitorsIBA 07/2023 - 02/2021
3	Allopurinol (Remid)FDA LinkGeneric 01/2023 - 01/2019
3	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2019
3	ChemokinesIBA 01/2021 - 05/2017
3	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020 - 01/2019
2	Immunoglobulin E (IgE)IBA 05/2024 - 01/2023
2	AllergensIBA 05/2024 - 04/2024
2	AntigensIBA 05/2024 - 01/2018
2	HLA-A Antigens (HLA-A)IBA 04/2024 - 01/2022
2	Peptides (Polypeptides)IBA 12/2023 - 01/2018
2	AutoantibodiesIBA 10/2023 - 01/2023
2	VaccinesIBA 10/2023 - 11/2022
2	ZincIBA 09/2023 - 02/2023
2	Genetic Markers (Genetic Marker)IBA 04/2023 - 01/2023
2	Interleukin-13IBA 01/2023 - 01/2022
2	SteroidsIBA 01/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2017
2	Antineoplastic Agents (Antineoplastics)IBA 02/2021 - 01/2018
2	EnzymesIBA 01/2020 - 01/2018
2	HLA-B57 antigenIBA 01/2020 - 11/2019
1	brodalumabIBA 05/2024
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2024
1	HLA-A*68 antigenIBA 04/2024
1	HLA-C Antigens (HLA-C)IBA 04/2024
1	Vitamin D FDA LinkGeneric 04/2024
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023
1	Peptide Hydrolases (Proteases)FDA Link 10/2023
1	Excipients (Suspending Agents)IBA 10/2023
1	baricitinibIBA 09/2023
1	tocilizumab (atlizumab)FDA Link 09/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Collagenases (Collagenase)FDA Link 01/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 11/2022
1	mRNA VaccinesIBA 11/2022
1	dupilumabIBA 10/2022
1	Immunoglobulin A (IgA)IBA 10/2022

Therapy/Procedure

14	Therapeutics 12/2023 - 01/2018
5	Immunotherapy 05/2024 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2023